Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 2
1984 3
1985 5
1986 4
1987 4
1988 3
1989 5
1990 7
1991 7
1992 6
1993 8
1994 9
1995 10
1996 7
1997 9
1998 9
1999 9
2000 14
2001 16
2002 13
2003 19
2004 19
2005 32
2006 29
2007 39
2008 38
2009 51
2010 40
2011 69
2012 67
2013 84
2014 73
2015 79
2016 51
2017 73
2018 88
2019 85
2020 90
2021 115
2022 112
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

1,241 results

Results by year

Filters applied: . Clear all
Page 1
Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus.
Lin R, Brown F, James S, Jones J, Ekinci E. Lin R, et al. Diabet Med. 2021 May;38(5):e14528. doi: 10.1111/dme.14528. Epub 2021 Mar 6. Diabet Med. 2021. PMID: 33496979 Review.
CONTEXT AND AIM: Continuous glucose monitoring (CGM) is becoming widely accepted as an adjunct to diabetes management. ...METHODS: A literature search was conducted by combining subject headings 'CGM' and 'flash glucose monitoring', with key wor …
CONTEXT AND AIM: Continuous glucose monitoring (CGM) is becoming widely accepted as an adjunct to diabetes management. …
Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring.
Jackson MA, Ahmann A, Shah VN. Jackson MA, et al. Diabetes Technol Ther. 2021 Mar;23(S1):S27-S34. doi: 10.1089/dia.2021.0007. Diabetes Technol Ther. 2021. PMID: 33534631 Free PMC article. Review.
The role of continuous glucose monitoring (CGM) in type 1 diabetes (T1D) is well established in improving glycemic control and reducing hypoglycemia. ...Although evidence is limited, early studies have indicated a role for rtCGM in selected patients with n
The role of continuous glucose monitoring (CGM) in type 1 diabetes (T1D) is well established in improving glycemic cont …
Continuous Glucose Monitoring-Guided Insulin Administration in Hospitalized Patients With Diabetes: A Randomized Clinical Trial.
Spanakis EK, Urrutia A, Galindo RJ, Vellanki P, Migdal AL, Davis G, Fayfman M, Idrees T, Pasquel FJ, Coronado WZ, Albury B, Moreno E, Singh LG, Marcano I, Lizama S, Gothong C, Munir K, Chesney C, Maguire R, Scott WH, Perez-Guzman MC, Cardona S, Peng L, Umpierrez GE. Spanakis EK, et al. Diabetes Care. 2022 Oct 1;45(10):2369-2375. doi: 10.2337/dc22-0716. Diabetes Care. 2022. PMID: 35984478 Free PMC article. Clinical Trial.
OBJECTIVE: The efficacy and safety of continuous glucose monitoring (CGM) in adjusting inpatient insulin therapy have not been evaluated. RESEARCH DESIGN AND METHODS: This randomized trial included 185 general medicine and surgery patients with type 1 and typ …
OBJECTIVE: The efficacy and safety of continuous glucose monitoring (CGM) in adjusting inpatient insulin therapy have n …
Glycemic variability and cardiovascular disease in patients with type 2 diabetes.
Martinez M, Santamarina J, Pavesi A, Musso C, Umpierrez GE. Martinez M, et al. BMJ Open Diabetes Res Care. 2021 Mar;9(1):e002032. doi: 10.1136/bmjdrc-2020-002032. BMJ Open Diabetes Res Care. 2021. PMID: 33762313 Free PMC article. Review.
Glycated hemoglobin is currently the gold standard for assessment of long-term glycemic control and response to medical treatment in patients with diabetes. Glycated hemoglobin, however, does not address fluctuations in blood glucose. Glycemic variability (GV …
Glycated hemoglobin is currently the gold standard for assessment of long-term glycemic control and response to medical treatment in patient …
Mobile App for Improved Self-Management of Type 2 Diabetes: Multicenter Pragmatic Randomized Controlled Trial.
Agarwal P, Mukerji G, Desveaux L, Ivers NM, Bhattacharyya O, Hensel JM, Shaw J, Bouck Z, Jamieson T, Onabajo N, Cooper M, Marani H, Jeffs L, Bhatia RS. Agarwal P, et al. JMIR Mhealth Uhealth. 2019 Jan 10;7(1):e10321. doi: 10.2196/10321. JMIR Mhealth Uhealth. 2019. PMID: 30632972 Free PMC article. Clinical Trial.
BACKGROUND: As the increasing prevalence of type 2 diabetes mellitus has put pressure on health systems to appropriately manage these patients, there have been a growing number of mobile apps designed to improve the self-management of diabete
BACKGROUND: As the increasing prevalence of type 2 diabetes mellitus has put pressure on health systems to appro …
Telemedicine-Assisted Self-Management Program for Type 2 Diabetes Patients.
von Storch K, Graaf E, Wunderlich M, Rietz C, Polidori MC, Woopen C. von Storch K, et al. Diabetes Technol Ther. 2019 Sep;21(9):514-521. doi: 10.1089/dia.2019.0056. Epub 2019 Jul 9. Diabetes Technol Ther. 2019. PMID: 31287736 Clinical Trial.
Background: Lifestyle interventions with personalized self-management programs have shown benefits for patients with type 2 diabetes mellitus (T2DM), a devastating highly prevalent disease worldwide. ...In addition, tele-assisted participants sh …
Background: Lifestyle interventions with personalized self-management programs have shown benefits for patients with type 2
The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.
Vigersky RA, McMahon C. Vigersky RA, et al. Diabetes Technol Ther. 2019 Feb;21(2):81-85. doi: 10.1089/dia.2018.0310. Epub 2018 Dec 21. Diabetes Technol Ther. 2019. PMID: 30575414
BACKGROUND: There has been recent recognition of the limitations of hemoglobin A1C (HbA1C) in describing both short- and long-term glycemic control. Continuous glucose monitoring (CGM) provides robust data about short-term glycemic control and provides metrics such …
BACKGROUND: There has been recent recognition of the limitations of hemoglobin A1C (HbA1C) in describing both short- and long-term glycemic …
Beyond HbA1c.
Bloomgarden Z. Bloomgarden Z. J Diabetes. 2017 Dec;9(12):1052-1053. doi: 10.1111/1753-0407.12590. Epub 2017 Sep 13. J Diabetes. 2017. PMID: 28792665
Although self-monitoring of capillary blood glucose (SMBG) is an important tool for patients to use in understanding glycemic excursions, CGM offers a far superior technology in this regard and can avoid the erroneous conclusions often accompanying the …
Although self-monitoring of capillary blood glucose (SMBG) is an important tool for patients to use in understan …
Self-Monitoring of Blood Glucose.
Garg SK, Hirsch IB. Garg SK, et al. Diabetes Technol Ther. 2019 Feb;21(S1):S4-S12. doi: 10.1089/dia.2019.2501. Diabetes Technol Ther. 2019. PMID: 30785324 Review. No abstract available.
Self-monitoring blood glucose improves glycemic control in type 2 diabetes without intensive treatment: A systematic review and meta-analysis.
Machry RV, Rados DV, Gregório GR, Rodrigues TC. Machry RV, et al. Diabetes Res Clin Pract. 2018 Aug;142:173-187. doi: 10.1016/j.diabres.2018.05.037. Epub 2018 May 30. Diabetes Res Clin Pract. 2018. PMID: 29857093 Review.
AIMS: Systematic review and meta-analysis to evaluate the effect of Self-Monitoring of Blood Glucose (SMBG) on glycemic control in patients with type 2 Diabetes (T2D). ...We also performed a manual search of abstracts from recent meetings of the …
AIMS: Systematic review and meta-analysis to evaluate the effect of Self-Monitoring of Blood Glucose (SMBG) on g …
1,241 results